Compositions and methods of cell attachment

US11536714B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11536714-B2
Application numberUS-201715648213-A
CountryUS
Kind codeB2
Filing dateJul 12, 2017
Priority dateJul 12, 2016
Publication dateDec 27, 2022
Grant dateDec 27, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions, devices and methods are described for improving adhesion, attachment, and/or differentiation of cells in a microfluidic device or chip. In one embodiment, one or more ECM proteins are covalently coupled to the surface of a microchannel of a microfluidic device. The microfluidic devices can be stored or used immediately for culture and/or support of living cells such as mammalian cells, and/or for simulating a function of a tissue, e.g., a liver tissue, muscle tissue, etc. Extended adhesion and viability with sustained function over time is observed.

First claim

Opening claim text (preview).

We claim: 1. A method of culturing cells, comprising: a) providing a microfluidic device comprising a microchannel comprising a polydimethylsiloxane surface, said polydimethylsiloxane surface reacted with an ultraviolet light reactive portion of a N-sulfosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate heterobifunctional crosslinker using an ultraviolet light source, said microchannel in fluidic communication with a fluid source comprising a fluid; b) covalently attaching one or more extracellular matrix proteins to a chemically-reactive portion of said heterobifunctional crosslinker so as to create a treated surface; c) seeding viable epithelial cells on said treated surface so as to create attached epithelial cells; d) flowing said fluid from said fluid source through said microchannel so as to create flowing conditions; and e) culturing said attached epithelial cells under said flow conditions such that said attached epithelial cells remain attached and viable for at least 7 days. 2. The method of claim 1 , wherein said one or more extracellular matrix proteins comprises collagen. 3. The method of claim 1 , wherein said one or ore extracellular proteins comprises RGD or a RGD motif. 4. A method of culturing cells, comprising: a) providing a microfluidic device comprising a microchannel comprising a polydimethylsiloxane surface, said surface reacted with an ultraviolet light reactive portion of a N-sulfosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate crosslinker using a source of ultraviolet light, said microchannel in fluidic communication with a fluid source comprising a fluid; b) covalently attaching one or more extracellular matrix proteins to a chemically-reactive portion of said crosslinker so as to create a treated surface; c) seeding viable hepatocytes on said treated surface so as to create attached cells; d) flowing said fluid from said fluid source through said microchannel so as to create flowing conditions; and e) culturing said attached cells under said flow conditions such that said cells remain attached and viable for at least 7 days. 5. The method of claim 4 , wherein said hepatocytes are dog hepatocytes. 6. The method of claim 4 , further comprising f) assessing viability of said hepatocytes by measuring the level of activity of one or more cellular enzymes. 7. The method of claim 6 , wherein said cellular enzyme is a cytochrome P450 (CYP) enzyme. 8. The method of claim 4 , wherein said one or more extracellular matrix proteins comprise collagen. 9. The method of claim 4 , wherein said one or more extracellular proteins comprises RGD or a RGD motif. 10. The method of claim 4 , wherein said polydimethylsiloxane surface is plasma treated prior to step b).

Assignees

Inventors

Classifications

  • Cross-linking · CPC title

  • Patterned coating · CPC title

  • C12N5/067Primary

    Hepatocytes · CPC title

  • Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG] · CPC title

  • Amino acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11536714B2 cover?
Compositions, devices and methods are described for improving adhesion, attachment, and/or differentiation of cells in a microfluidic device or chip. In one embodiment, one or more ECM proteins are covalently coupled to the surface of a microchannel of a microfluidic device. The microfluidic devices can be stored or used immediately for culture and/or support of living cells such as mammalian c…
Who is the assignee on this patent?
Emulate Inc
What technology area does this patent fall under?
Primary CPC classification C12N5/067. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).